Banner

Glaucoma management update draws from clinical trials

Article

Global assessment will become a more prevalent concept in glaucoma management.

Related Videos
Related Content

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023
© 2023 MJH Life Sciences

All rights reserved.